Parabilis Repositions: Rare-Disease Core with an Unclaimed Oncology Leftover
Parabilis has pivoted into a foundation built around rare-disease assets while effectively relinquishing a capital-intensive oncology pipeline. That repositioning creates a clear, fundable pathway to clinical value capture and near-term binary events. Risk is high, but asymmetric upside and a clear set of catalysts make a disciplined long trade att…